ARX News and Press, Accelerant Holdings Class A From 12/03/25

2025-12-03 22:06:29 ET from JMP Securities issued a price target of $20.00 for ARX on 2025-12-04 02:07:38. The adjusted price target was set to $20.00. At the time of the announcement, ARX was trading at $14.15. The overall price target consensus is at $19.67 with high p...

2025-12-03 21:15:05 ET Citigroup analyst issues OUTPERFORM recommendation for ARX on December 4, 2025 02:07AM ET. The previous analyst recommendation was Market Perform. ARX was trading at $14.15 at issue of the analyst recommendation. The overall analyst consensus : BUY...

2025-11-14 16:53:56 ET More on Spire: Data Center Thesis May Be Fraying, But Company Still On Growth Trajectory Beyond Meat: Out Of Options Lendlease Group (LLESY) Shareholder/Analyst Call Transcript Entera Bio GAAP EPS of $0.07 Vizsla Copper upsizes ...

2025-11-13 12:33:29 ET More on Accelerant Holdings Accelerant: A Disruptive Play In Specialty Insurance Accelerant Holdings (ARX) Q2 2025 Earnings Call Transcript Crypto names IREN, Hut 8 among gainers: Accelerant tanks in week's financial movers Accelerant g...

2025-11-13 06:52:56 ET More on Accelerant Holdings Accelerant: A Disruptive Play In Specialty Insurance Accelerant Holdings (ARX) Q2 2025 Earnings Call Transcript Crypto names IREN, Hut 8 among gainers: Accelerant tanks in week's financial movers Accelerant g...

GRI Bio Inc. (GRI) is expected to report $-1.11 for Q3 2025 Meridian Mining UK Societas (MRRDF) is expected to report $-0.01 for Q3 2025 CaliberCos Inc. (CWD) is expected to report $-0.32 for Q3 2025 BioCorRx Inc (BICX) is expected to report $-0.06 for Q3 2025 Beneficient (BENF) i...

Exchange Written Premium of $1.043 billion grew 17% year-over-year and 39% on a year-to-date basis Net loss of $1.367 billion driven by non-cash and equity-neutral profits interest distribution expenses Adjusted net income of $79.8 million, up 320% over the prior year ...

2025-10-20 21:54:27 ET Accelerant ( ARX ) is a newly listed player in the specialty insurance market, having IPO’d on the NYSE on 24th July, making a strong debut as shares rose 36% , valuing the company at $6.4bn.... Read the full article on Seeking Alpha For...

2025-10-07 13:23:25 ET from Morgan Stanley issued a price target of $18.00 for ARX on 2025-10-07 15:53:04. The adjusted price target was set to $18.00. At the time of the announcement, ARX was trading at $14.72. The overall price target consensus is at $21.67 with high p...

2025-10-06 07:15:10 ET Goldman Sachs analyst issues BUY recommendation for ARX on October 6, 2025 09:12AM ET. The previous analyst recommendation was Neutral. ARX was trading at $14.9 at issue of the analyst recommendation. The overall analyst consensus : BUY. Curren...